The LOTTI study, based in Italy, found that patients taking highly active retroviral treatment (HAART) for HIV/AIDS who took a “vacation” from drug treatment fared as well as those who remained on their drugs continuously.
This study offers a desperately needed offer of hope for those in treatment who cannot tolerate the AIDS drugs’ toxicity, or who want to avoid know side effects such as disfigurement and organ failure.